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Abstract 
Stimulated by retinoic acid 6 (STRA6) was the first protein to be identified in a novel 
category of proteins, cytokine signaling transporters, due to its ability to function as both 
a cell surface receptor and a membrane protein that binds to retinol binding protein 
facilitating cellular uptake of retinol. Retinol is metabolized to all-trans retinoic acid 
which functions as a steroid hormone transcription factor ligand to regulate genes 
generally involved in cellular differentiation. The role of vitamin A, as all-trans retinoic 
acid, in immunity is well characterized, but the role of STRA6 in mediating cellular 
uptake of vitamin A in immune cells is not understood. The objective of this research 
was to characterize the expression of STRA6 on human peripheral blood mononuclear 
cell (PBMC) subsets. We hypothesized STRA6 would be expressed by all PBMC 
subsets, but at different intensities. We also hypothesized STRA6 would be co-localized 
with the lipid raft. A convenience sample of volunteers were recruited and PBMC were 
isolated by density gradient centrifugation. Multicolor flow cytometry was used to identify 
PBMC subsets and expression of STRA6. Confocal microscopy was used to determine 
cellular location and lipid raft association of STRA6 on cell lines and isolated PBMC. All 
T cell, natural killer cell, monocyte, and dendritic cell subsets analyzed expressed 
STRA6. Median fluorescence intensity of STRA6 was higher on pDC dendritic cells 
compared to mDC2 and mDC1 dendritic cells, cytotoxic T lymphocytes compared to T 
helper lymphocytes, intermediate compared to nonclassical and classical monocytes, 
and cytokine natural killer cells compared to both cytotoxic and CD56-/CD16 dim natural 
killer cells. Age was the best predictive factor for STRA6 expression. Confocal 
microscopy showed STRA6 was not associated with GM1 cholera toxin subunit B 
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staining and therefore not associated with lipid raft structures. These results provide 
preliminary data in which to target vitamin A signaling, through cellular uptake of retinol, 
in immune cells to improve immune homeostasis in diverse populations. With further 
research and development, STRA6 signaling in immune cells may be a therapeutic 
target for immune mediated diseases.   
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1. Literature Review 
1.1 Stimulated by Retinoic Acid 6 
Stimulated by retinoic acid (STRA6), initially identified in 1995 using an 
embryonic carcinoma P19 cell line, was known to be a retinoic acid (RA) induced gene 
with unknown function (Bouillet et. al., 1997). In 2007, the function of STRA6 was fully 
characterized through the use of confocal microscopy and assays performed on bovine 
retinal pigmented epithelium cells and WiDr human colon adenocarcinoma cells. It was 
identified as the receptor for retinol binding protein (RBP) based on the following 
criteria; the ability to bind RBP to the plasma membrane, facilitate cellular uptake of 
retinol, and for its localization to the cellular locations expected of RBP receptor 
(Kawaguchi et. al., 2007). STRA6 is the first and only protein to be classified in a novel 
class of proteins called cytokine signaling transporters. It is classified as such for its 
dual ability to act as a membrane transporter facilitating intracellular uptake of retinol 
and a cell surface receptor activating the janus kinase/signal transducer and activator of 
transcription (JAK/STAT) signaling cascade (Berry et. al., 2012).  
STRA6 is a membrane bound protein with 19 distinct domains; 5 extracellular 
domains, 9 transmembrane domains, and 5 intracellular domains (Sun & Kawaguchi, 
2007). The 9 transmembrane domains allow STRA6 to facilitate catalytic bidirectional 
transport of retinol from RBP and across the cellular membrane, which is distinct from 
any other known transport mechanisms. RBP exists in two forms, apo-RBP without 
retinol bound, and holo-RBP, which has retinol bound. When holo-RBP binds, STRA6 is 
phosphorylated, leading to the recruitment and activation of JAK2. Phosphorylated 
STRA6 has the ability to open holo-RBP, allowing retinol to disassociate from RBP and 
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be transported to the intracellular side of the cell via a defined pathway involving the 
transmembrane domains of STRA6 (Berry et. al., 2012 & Kawaguchi et. al., 2015). 
Intracellularly, retinol influences expression of over 500 genes associated with 
inflammation, cellular differentiation, proliferation, apoptosis, and metabolism 
(Amengual et. al., 2014). These effects are mediated by retinoic acid receptor (RAR)-
retinoid X receptors (RXR) heterodimers or by RXR homodimers functioning as 
transcription factors that bind to retinoic acid response elements (RARE) (Conway, 
Henning, & Lerner, 2013). This pathway controls vitamin A concentrations by ensuring 
that vitamin A is only taken up by target cells when they have the ability to store it, 
preventing vitamin A from reaching toxic levels.  
Phosphorylation of STRA6 by JAK2 also triggers the recruitment and activation 
of STAT3 or STAT5 and their corresponding signaling cascades. Upon activation, 
STAT3 dimerizes and translocates to the nucleus to function as a transcription factor 
driving oncogenesis (Karunanithi et. al., 2017). STAT5 activation induces the 
expression of its target genes including suppressor of cytokine signaling 3 (SOCS3), a 
known inhibitor of insulin signaling, leading to insulin resistance and reduced responses 
to inflammatory cytokines (Berry et. al., 2012).  
1.2  Vitamin A Metabolism 
Vitamin A is obtained from the diet by consumption of vitamin A precursors, 
retinyl esters or carotenoids. Precursors are converted to retinoids in the lumen of the 
proximal portion of the gut by enterocytes, incorporated into chylomicrons, and then 
enter circulation (Rosa Bono et. al., 2016). When chylomicrons reach the liver, retinyl 
esters leave circulation and are stored. In the liver retinyl esters are hydrolyzed into 
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retinol allowing them to bind to RBP and re-enter circulation maintaining a relatively 
narrow serum concentration of retinol. Intracellularly, retinol goes through two 
consecutive reactions to generate the main metabolite of vitamin A, retinoic acid (RA). 
Retinol is reversibly oxidized to retinaldehyde by retinol (or other non-specific alcohol) 
dehydrogenases and is then irreversibly oxidized to retinoic acid by one of three retinal 
dehydrogenase isoforms RALDH1, RALDH2, or RALDH3 (Conaway, Henning, & 
Lerner, 2013 & Rosa Bono et. al., 2016). RA exists as all-trans-RA or 9-cis-RA that bind 
to one of two nuclear hormone receptors, RXR or RAR. All-trans RA or 9-cis-RA binding 
and activation of RAR or 9-cis-RA binding and activation of RXR are responsible for 
mediating the majority of the immunological functions associated with vitamin A.   
1.3  Vitamin A and Immunity 
Vitamin A was initially described as an anti-infective agent in the early 20th 
century and is arguably the most multifunctional vitamin in the human body due to its 
role in human survival at every point in development (Ross, 2012 & Kawaguchi et. al., 
2015). Vitamin A has pleiotropic effects in immunity and is associated with aspects of 
the innate and adaptive immune responses; maintaining skin integrity, mucosal barriers, 
lymph node development, and immune response and regulation, and leukocyte 
trafficking (Duriancik, Lackey, & Hoag, 2012; Ross, 2012; Rosa Bono et. al., 2016). 
Despite this knowledge, vitamin A deficiency remains one of the most common 
micronutrient deficiency and primary cause of immunosuppression worldwide (Rosa 
Bono et. al., 2016). In addition to impaired barriers, individuals suffering from vitamin A 
deficiency have impaired immune cell functions. Natural killer (NK) cell and neutrophil 
function is reduced in vitamin A deficient populations. Generally, vitamin A deficient 
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individuals have reduced T helper type 2 (TH2) immunity and unaffected or increased T 
helper type 1 (TH1) immunity. The effects on adaptive immunity are due to both direct 
effects of vitamin A deficiency on transcription regulation of B and T lymphocytes, as 
well as indirect effects of B and T lymphocyte stimulation through impaired activation of 
antigen presenting cells such as dendritic cells (DC).   
Vitamin A deficiency causes immunosuppression by impacting immune cell 
responses and concentrations. Neutrophil concentration is increased in the spleen, 
peripheral blood, and bone marrow, but they are decreased in their ability to migrate to 
infection sites and phagocytose bacteria (Duriancik, et. al., 2012). Macrophages ability 
to migrate to infection sites and phagocytose bacteria is also compromised during 
deficiency. A decrease in overall NK cell cytotoxicity due to decreased concentration 
and decreased monocyte concentration in the spleen and bone marrow is observed 
during vitamin A deficiency (Duriancik, et. al., 2012). Deficiency also impacts immune 
cell responses by mediating the responses of CD4+ T lymphocytes.  
Differentiation of naïve CD4+ T lymphocytes is dependent on their cell to cell 
contact with antigen presenting cells, DC, macrophages, and B lymphocytes, whose 
cytokine production are mediated by retinoic acid (Duriancik, et. al., 2012 & Ross, 
2012). Retinoic acid isoforms can also directly impact naïve T lymphocyte differentiation 
by regulating their transcription factor function. Retinoic acid via RXR binding initiates 
interleukin-4 production by naïve T lymphocytes initiating increased TH2 differentiation 
while suppressing TH1 (Rosa Bono et. al., 2016). Through the RAR pathway, DC 
facilitate the differentiation of naïve T lymphocytes into T regulatory (Treg) lymphocytes 
at the expense of TH17 (Rosa Bono et. al., 2016). T lymphocyte impairment in vitamin A 
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deficiency is also due to indirect effects on antigen presenting cells ability to stimulate T 
helper lymphocytes. This leads to impairment of TH2 lymphocyte function, ultimately 
resulting in decreased antibody production from B cells including IgM, IgA, and IgG. 
1.4  Vitamin A and Immune Cell Metabolism 
All immune cells express RAR and RXR and respond to retinoic acid through 
transcriptional regulation. However, murine cluster of differentiation (CD) 103+ DC 
express RALDH2 and are able to metabolize retinol to retinoic acid (Molenaar et. al., 
2011). The resultant retinoic acid either regulates genes in CD103+ DC or is released 
from CD103+ DC to affect transcription in local T and B lymphocytes. Lymphocytes, 
including T, B, and NK cells, are not known to express RALDH2 and therefore need to 
rely on exogenous retinoic acid isoforms to regulate genes via RAR/RXR transcription 
factors.  
1.5  PBMC Phenotype and Function  
There are several types of leukocytes within a peripheral blood mononuclear 
(PBMC) isolation from human samples. These include natural killer T lymphocytes 
(NKT), natural killer lymphocytes (NK), B lymphocytes, T lymphocytes, monocytes, and 
dendritic cells (DC). There are also several cell subsets within each different type of 
lymphocyte.  
Natural killer T lymphocytes are identified using the following cluster of 
differentiation markers, CD3+/CD56+/CD19-. NKT cells are known to recognize lipid 
antigens presented by CD1d that are elevated during inflammatory response (Fox et. 
al., 2009). B lymphocytes (CD3-/CD56-/CD19+) are a crucial part of the adaptive 
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immune response and are responsible for producing antibodies in response to infection 
and presenting antigens. To function properly, B lymphocytes must first be activated by 
cytokines produced by T helper lymphocytes (CD3+/CD8-/CD4+). Cytotoxic T 
lymphocytes (CD3+/CD8+/CD4-) induce apoptosis in cells that have been infected by 
virus and cancer cells.  
Natural killer cells are categorized into one of three subsets, cytotoxic (CD3-
/CD56hi/CD16var), cytokine (CD3-/CD56dim/CD16+), and CD56dim/CD16- (CD3-/CD56dim/CD16-). 
Cytotoxic NK cells proliferate, produce cytokines upon stimulation, and may be precursors to 
cytokine and CD56dim/CD16- NK cells (Björkström et. al., 2010). Cytokine NK cells’ main 
function is to produce cytokines and induce apoptosis in virus infected cells and cancer cells.   
Monocytes are also categorized into three subsets, classical (inflammatory; CD4-
/CD14+/CD16-), nonclassical (patrolling; CD3-/CD14-/CD16+), and intermediate (CD3-
/CD14+/CD16+). Intermediate monocytes highly express genes involved in T lymphocyte 
stimulation, antigen presentation, and are precursors to both patrolling and inflammatory 
subsets (Wong et. al., 2011). Nonclassical monocytes are highly motile cells that express 
genes involved in cytoskeletal rearrangement and phagocytosis to initiate immune responses. 
Classical monocytes secrete the broadest range of cytokines and chemokines, many of which 
involved in proinflammatory tissue repair.  
Dendritic cells are also categorized into three subsets, mDC1 (CD14-/CD19-
/CD1c+/CD141-/CD303-), mCD2 (CD14-/CD19-/CD1c-/CD141+/CD303-), and pDC (CD14-
/CD19-/CD1c-/CD141-/CD303+). The mDC1 subset is unique because these cells express toll 
like receptor-3, cross-present antigen to CD8+ T lymphocytes, and produce high levels of 
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interleukin-12, promoting TH1 responses (Eisenbarth, 2018). mDC2 primary function is to 
present antigen to CD4+ T lymphocytes. pDC secrete large amounts of type 1 interferon, 
promoting protection from viruses in nearby cells. These immune cells work in combination to 
protect the human body from bacteria, virus, and disease.  
1.6  Hypothesis  
Due to the importance of vitamin A in immune cell development, STRA6 is 
hypothesized to be expressed on all peripheral blood mononuclear cell subsets at 
varying intensities. Intensity of expression will be dependent on cell type as well as 
demographic and anthropometric data. If PBMC subsets express STRA6, then the 
expression will be co-localized with the lipid raft due to its intracellular cytokine signaling 
through the JAK/STAT pathway.  
2. Methods 
2.1 Participants 
Human subjects were recruited via a convenience sample from University of 
Michigan-Flint students, faculty, staff, and residents living in the surrounding area. 
Subjects were verbally screened and provided written consent. The inclusion criteria 
included no clotting disorders, no known chronic or infectious disease, not currently 
pregnant, and above eighteen years of age. Subjects self-reported birthdate, 
race/ethnicity, and physical activity, and were measured for height, weight, and percent 
body fat using bioelectrical impedance (Tanita).  All protocols were approved by the 
University of Michigan Flint Institutional Review Board.  
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2.2 Blood Sample Collection and Processing 
A certified phlebotomy technician collected three volumes of venous blood into 
heparinized vacutainer tubes (BD Biosciences: San Jose, CA) using standard 
techniques. Heparinized whole blood was layered over an equal volume of room 
temperature Histopaque 1077 (Thermo Fisher Scientific; Waltham, MA). Density 
gradient centrifugation was performed at 400xg, 25C, 30 minutes without braking. The 
buffy coat was removed, fluorescence activated cell sorting (FACS) buffer [5% fetal 
bovine serum (FBS), 0.1% sodium azide, in Ca++/Mg++-free Dulbecco’s Phosphate 
Buffered Saline] (Thermo Fisher Scientific) was added to wash the cells, and then were 
centrifuged at 320xg, 25C, for 10 minutes to pellet. The supernatant was poured off and 
cells were resuspended in the residual volume. Cells resuspended in FACS buffer were 
diluted in trypan blue (Thermo Fisher Scientific) for hemocytometer cell counts.   
2.3 ARPE-19 Cell Processing 
Undifferentiated retinal pigmented epithelium-19 (ARPE-19) cells were obtained 
from American Tissue Type Culture Collection (Manassas, VA). Cells were cultured in 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Thermo Fisher Scientific) media 
supplemented with 1% FBS, penicillin, streptomycin, and sodium pyruvate for seven to 
ten days (Samual et. al., 2017). Accutase (Thermo Fisher Scientific) was then used to 
remove the adherent cells. Cells were washed with FACS buffer by centrifugation at 
320xg, 25C, 10 minutes to pellet. After centrifugation, the supernatant was poured off 
and cells were resuspended in the residual volume. Cells were resuspended in FACS 
buffer and hemacytometer cell counts were completed using trypan blue.  
 
 
11 
2.4 Flow Cytometry of PBMC Subsets  
Aliquots of 1-5 million cells were dispensed into 5mL round bottom tubes.  Cells 
were then stained in the dark and on ice for thirty minutes using specific antibody 
cocktails (Table 1). After staining, FACS buffer was added and cells were centrifuged at 
320xg, 4C, for 10 minutes to pellet. The supernatant was poured off and cells were 
resuspended in the residual volume. This process was repeated for a total of three 
washes. Cytofix/Cytoperm (BD Biosciences: San Jose, CA) solution was added and 
cells were incubated on ice for thirty minutes. Cells were washed with Perm/Wash 
buffer (BD Biosciences) and centrifugation 530xg, 4C, 10 minutes to pellet. The 
supernatant was poured off and cells resuspended. The cells were stored in 
Perm/Wash buffer 14-40 hours at 4C. Cell were centrifuged at 530xg, 4C, for 10 
minutes to pellet, the supernatant was poured off, and the cells were resuspended. 
Cells were incubated with either STRA6-AF488 (R&D Systems; Minneapolis, MN) or the 
isotype (BD Biosciences) for thirty minutes. Cells were then washed three times with 
Perm/Wash Buffer via centrifugation at 520xg, 4C, for 10 minutes to pellet. The 
supernatant was poured off, cells were resuspended in the residual volume, and data 
were acquired on a BD Biosciences FACS Calibur or FACS Canto II flow cytometer. 
Each subset was acquired on the same flow cytometer for consistency.  All data were 
analyzed following standard gating strategies using FlowJo software (Ashland, OR) 
(Table 2). 
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Table 1. Antibody cocktails for flow cytometry. 
1All antibodies were used at 1x concentration as recommended by manufacturer (BD 
Biosciences). Master mixes were made using FACS buffer. 
 
 
 
Subset Antibody1 
PBMC anti-CD3-Alexa Fluor488 
anti-CD56-PE 
anti-CD19-PerCp-eFluor710 
T Cell anti-CD3-Alexa Fluor488 
anti-CD8-PE 
anti-CD4-PerCp-eFluor710 
NK Cell anti-CD3-Alexa Fluor488 
anti-CD56-PE 
anti-CD16-PerCp-eFluor710 
Monocytes anti-CD3 Alexa Fluor488 
anti-CD16 PerCp-eFluor710 
anti-CD14 PE 
DC anti-CD1c FITC 
anti-CD141 PE 
anti-CD14 PerCp-eFluor710 
anti-CD19 PerCp-eFluor710 
anti-CD303 AF700 
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Table 2. PBMC subset gating strategies 
 
Cell Type Subset CD Markers 
PBMC   
 NK CD3-/CD56+/CD19- 
 NKT CD3+/CD56+/ CD19- 
 B lymphocytes CD3-/CD56-/CD19+ 
T Cell   
 Cytotoxic T lymphocytes CD3+/CD8+/CD4- 
 T helper lymphocytes CD3+/CD8-/CD4+ 
NK cells   
 Cytotoxic CD3-/CD56hi/CD16var 
 Cytokine CD3-/CD56dim/CD16+ 
 CD56dim/CD16- CD3-/CD56dim/CD16- 
Monocytes   
 Classical CD3-/CD14+/CD16- 
 Nonclassical  CD3-/CD14-/CD16+ 
 Intermediate CD3-/CD14+/CD16+ 
Dendritic Cells   
 mDC1 CD14-/CD19-/CD1c+/CD141-/CD303- 
 mDC2 CD14-/CD19-/CD1c-/CD141+/CD303- 
 pDC CD14-/CD19-/CD1c-/CD141-/CD303+ 
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2.5 ARPE-19 Cells and PBMC Confocal Microscopy 
After hemocytometer cell counts, volumes were aliquoted so each tube contained 
1x106 cells. Cells were stained in the dark using a Vybrant Alexa Fluor 488 kit (Thermo 
Fisher Scientific), according to manufacturer instructions. Cells were incubated for 
twenty minutes on ice with CT-B-AF488 (BD Biosciences) to stain for the lipid raft. Cells 
were then washed in PBS via centrifugation at 320xg, 4C, for 10 minutes to pellet. 
Supernatant was poured off to waste and cells were resuspended in the residual 
volume. This was repeated for a total of three washes. The cells were then incubated 
with anti-CT-B (BD Biosciences) serum for fifteen minutes. The cells were washed three 
times in PBS via centrifugation at 320xg, 4C, for 10 minutes to pellet. Cells were then 
fixed and permeabilized by adding Cytofix/Cytoperm solution and incubated for thirty 
minutes. After incubation, the cells were washed three times with Perm/Wash via 
centrifugation 320xg, 4C, for 10 minutes to pellet. Cells were then stained with optimal 
concentrations of STRA6-AF647 or isotype for thirty minutes. The stain was washed out 
using Perm/Wash via centrifugation at 320xg, 4C, for 10 minutes to pellet. The cells 
were then stained with Hoechst 33342 (Thermo Fisher Scientific) for five minutes to 
stain for the nucleus. Cells were then washed twice, first with Perm/Wash and then with 
PBS via centrifugation 320xg, 4C, for 10 minutes to pellet. The supernatant was poured 
off to waste and the cells were loaded into vitro tubes to be viewed on a TCS SPE DMi8 
confocal microscope (LEICA; Buffalo Grove, IL). Images were obtained using a 63X oil 
immersion objective and a frame average of four with LASX software (LEICA). Settings 
to capture fluorescence were; Hoechst 33342, 405nm laser, 33.3% laser power, 
emission filter 410-520, gain 800 volts; AlexaFluor488, 488nm laser, 33.3% laser power, 
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emission filter 505-590nm, gain 1250 volts; AlexaFluor647, 635nm laser, 33.3% laser 
power, emission filter 650-770nm, gain 1250 volts. The differential interference contrast 
image was also collected. Images were then processed using Fiji (ImageJ) (NIH).  
2.6 Statistical Analyses 
Forty subjects was the determined n after using G*Power 3.1.9.2 a priori linear 
multiple logistic regression fixed model R2 deviation from zero power analysis with 4 
predictors variables, a large effect size of 0.26, alpha 0.05, and beta 0.2. The predictor 
variables included age, sex, race/ethnicity, and body composition. Multiple linear 
regression was performed using R on the expression of STRA6 on each cell population. 
ANOVA with Tukey’s post hoc multiple comparisons in Prism was used for cell 
population differences.  
3. Results 
3.1 Demographic and Anthropometric Analyses 
Power analysis results determined 40 subjects would be required to observe a 
significant difference with large effect size, alpha at 0.05, beta at 0.2, for a multiple 
linear regression analysis. Forty-one human subjects were recruited to participate in this 
study. One subject had unusual PBMC scatter profiles, subset marker expression, and 
high STRA6 MFI in all cell populations; therefore, this subject was considered an outlier 
and not included in the following analysis.  
Participants self-reported as being predominately white (75%, 12.5% black) 
females (60%) with a mean age of 28.28 + 1.58 calculated by their birthdate (Table 3). 
Body composition was measured in each participant. The mean body fat percentage 
was 28.20 + 1.87. The mean body mass index was 27.45 + 0.81 kg/m2, with overall 
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composition in the following categories as defined by the Center for Disease Control 
(CDC); 2.5% underweight, 35% normal, 25% overweight, 25% obese, and 25% obese 
II. 45% of participants self-reported to be athletic, defined according to Tanita as 
“Athlete”  over 16 years old and exercised ten our more hours per week for the past six 
months, or a resting heart rate (HR) of 60 beats per minutes or less, or “very fit” for 
years, but currently exercises less than or equal to ten hours a week. 
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Table 3. Demographic and anthropometric data 
 
Characteristic  Mean + SEM 
Race/Ethnicity  75% White, 12.5% Black1 
Sex  60% Female 
Age  28.28 + 1.58 
Height (m)  1.72 + 0.01 
Body Weight (Kg)  81.58 + 2.98 
Body Composition   
 Body Mass Index 27.45 + 0.80 
 % in each BMI Category2 35% Normal 
  25% Overweight 
  25% Obese 
  12.5% Obese II 
 Body Fat% 28.20 + 1.87 
 Body Fat (Kg) 23.93 + 2.08 
 Lean Body Mass %3 71.80 + 1.837 
 Lean Body Mass (Kg) 57.65 + 2.08 
Lifestyle4  45% Athletic 
 
1Race/ethnicity as defined by NIH. Remaining percentage was Asian 
2BMI categories as defined by CDC; Normal 18.5-24.9, Overweight 25.0-29.9, Obese 
30.0-34.9, Obese II > 35.0 
3Calculated as 100% -% body fat 
4Defined according to Tanita as “Athlete” >16yo + 10 hours/week for 6 months, OR 
resting HR ~60bpm, OR “very fit” for years, but currently < 10 hours/week 
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3.2 PBMC STRA6 Expression   
 One million PBMC were stained separately for CD3, CD56, and CD19 to identify 
NKT, NK, and B lymphocytes. Of the subsets identified, NKT cells expressed 
significantly more STRA6, with a mean MFI of 286.63 + 33.89, compared to total NK 
cells (233.02 + 28.69, Tukey’s p < 0.001) and B lymphocytes (105.93 + 17.18, Tukey’s p 
< 0.0001) (Figure 1). The mean MFI of STRA6 on NK cells was significantly higher than 
the mean MFI of B lymphocytes (Tukey’s p < 0.0001).  
 One million cells were stained separately for CD3 and CD4 to identify T helper 
lymphocytes and CD8 to identify cytotoxic T lymphocytes. Of the two cell types, CD8+ T 
cytotoxic lymphocytes expressed significantly higher STRA6 with a mean MFI of 225.68 
+ 28.45 compared to CD4+ T helper lymphocytes, whose mean MFI was 179.91 + 22.09 
(Student’s t-test p < 0.0001) (Figure 2).  
 Three million cells were stained separately for CD3, CD56, and CD16 to identify 
three subsets of NK cells. Cytokine NK cells had a mean MFI of 176.31 + 23.21 which 
was significantly higher than the mean MFI of CD56dim/CD16- NK cells, 164.12 + 21.34 
(Tukey’s p = 0.0171) (Figure 3). Cytotoxic had a mean MFI of 166.86 + 20.41 and was 
not significantly different from the other two cell populations.  
 Three million cells were stained separately for CD3, CD16, and CD14 to identify 
classical, nonclassical, and intermediate monocytes. Nonclassical monocytes had a 
mean MFI of 1,089.81 + 184.73, which was significantly higher than classical 
(CD14+/CD16-) (Tukey’s p = 0.0002) and intermediate monocytes (Tukey’s p < 0.0001) 
(Figure 4). Classical monocytes had a mean MFI of 454.70 + 58.01, which was 
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significantly higher than intermediate monocytes mean MFI of 371.62 43.60 (Tukey’s p 
< 0.0001). 
 Five million cells were stained separately for CD1c, CD141, CD14, CD19, and 
CD303 to identify three subsets of dendritic cells. pDC dendritic cells had a mean MFI of 
5,939.83 + 901.35, which was significantly higher than the mean MFI of mDC2 at 
4,289.97 +  474.30 (Tukey’s p = 0.05) (Figure 5). mDC1 had a mean MFI of 5,040.53 + 
766.46 and was not significantly different than either of the other dendritic cell subsets.   
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Figure 1. Expression of STRA6 on NKT, NK, and B lymphocytes. One million PBMC 
were stained for CD3, CD56, and CD19 to identify total NK cells (CD3-/CD56+/CD19-), B 
lymphocytes (CD3-/CD56-/CD19+) and NKT cells (CD3+/CD56+CD19-). Expression of 
STRA6 on NKT cells was significantly increased compared to NK cells and B 
lymphocytes, and NK cells expressed significantly higher STRA6 than B lymphocytes. 
Data represent mean + SEM (n=41) and bars with different letters were statistically 
significant at p < 0.05 by ANOVA with Tukey’s post-hoc analysis.   
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Figure 2. Expression of STRA6 on T helper and T cytotoxic lymphocytes. One 
million PBMC were stained for CD3, CD8, and CD4 to identify total T helper (CD4+) and 
T cytotoxic (CD8+) lymphocytes. Expression of STRA6 on T cytotoxic lymphocytes was 
significantly increased compared to T helper lymphocytes. Data represent mean + SEM 
(n=32) and bars and asterisk indicate statistically significant at p < 0.05 by Student’s t-
test.  
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Figure 3. Expression of STRA6 on cytotoxic, cytokine, and CD56dim/CD16-  NK 
cells. Three million PBMC were stained for CD3, CD56, and CD16 to identify cytotoxic 
(CD3-/CD56hi/CD16var) cytokine (CD3-/CD56dim/CD16+) and CD56dim/CD16- NK cells. 
Expression of STRA6 on cytokine NK cells was significantly increased compared to 
CD56dim/CD16- NK cells, but not cytotoxic NK cells. Data represent mean + SEM (n = 
40) and bars with different letters were statistically significant at p < 0.05 by ANOVA 
with Tukey’s post-hoc analysis.   
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Figure 4. Expression of STRA6 on classical, nonclassical, and intermediate 
monocytes. Three million PBMC were stained for CD3, CD16, and CD14 to identify 
total classical (CD3-/CD14+/CD16-) nonclassical (CD3-/CD14-/CD16+) and intermediate 
(CD3-/CD14+/CD16+) monocytes. Expression of STRA6 on nonclassical monocytes was 
significantly increased compared to classical and intermediate monocytes, and 
expression of STRA6 on classical monocytes was significantly increased compared to 
intermediate monocytes. Data represent mean + SEM (n = 38) and bars with different 
letters were statistically significant at p < 0.05 by ANOVA with Tukey’s post-hoc 
analysis.   
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Figure 5. Expression of STRA6 on mDC1, mDC2, and pDC dendritic cells. Five 
million PBMC were stained for CD14, CD19, CD1c, CD141, and CD303 to identify total 
mDC1, mDC2, and pDC dendritic cells. Expression of STRA6 on pDC cells was 
significantly increased compared to mDC2, but not mDC1. Data represent mean + SEM 
(n = 37) and bars with different letters were statistically significant at p < 0.05 by 
ANOVA with Tukey’s post-hoc analysis.   
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3.3 Predictive Factors for STRA6 Expression 
 We hypothesized age, race/ethnicity, body composition (body fat percentage), 
and sex would be predictive of STRA6 expression. However, in no model for any cell 
population was body fat percentage, sex, or race/ethnicity significantly predictive of 
STRA6 expression. Backwards mixed effects linear regression consistently indicated 
that age was the most predictive factor for STRA6 expression.  
Although not statistically significant, age was the most predictive factor for 
STRA6 expression on NK cells (p = 0.0933), NKT cells (p = 0.105), and B lymphocytes 
(p = 0.072). Age was a significant predictive factor for STRA6 expression on classical 
monocytes and was significant alone (p = 0.0381) or in combination with all other 
factors; sex, race/ethnicity, and body fat percentage (p = 0.0467) (Figure 6). Age was 
also the best predictive factor, not significantly, for STRA6 expression on nonclassical 
(p = 0.119) and intermediate monocytes (p = 0.0817).  
Age was the most predictive factor for STRA6 expression on all NK cell subsets; 
cytotoxic (p = 0.2084), cytokine (p = 0.2055), and CD56dim/CD16- (p = 0.1807). The 
most predicative factor for STRA6  expression on T lymphocyte subsets was age, for 
both T helper (p = 0.2215) and T cytotoxic (p = 0.2215). Age was also the most 
predictive factor for STRA6 expression on all dendritic cell subsets: mDC1 (p = 0.4484), 
mDC2 (p = 0.2042), and PDC (p = 0.2311).  
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Figure 6. Age significantly predicts median fluorescent intensity on classical 
monocytes. Backwards mixed effects linear regression indicates that age is a 
significant predicative factor for median fluorescent intensity (MFI) of the STRA6-AF488 
antibody expression of classical monocytes alone (p = 0.0381; shown) and in 
combination with body composition, sex, and race/ethnicity (p = 0.0467).  
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4. Discussion 
All PBMC subsets expressed STRA6 at varying intensities, which is to our 
knowledge the first characterization of STRA6 on human immune cells. As a cell 
population, monocytes were found to have the greatest level of expression of STRA6 
compared to NK, NKT, B lymphocytes, and T lymphocytes. Within each cell population, 
differences in expression were also detected amongst the identified subsets. From the 
subsets identified with the PBMC cocktail of antibodies, NKT cells had the greatest level 
of expression of STRA6. T cytotoxic lymphocytes had increased expression compared 
to T helper lymphocytes. Cytokine NK cells had increased expression of STRA6 
compared to cytotoxic and CD56dim/CD16 NK cell subsets. STRA6 expression was 
increased in nonclassical monocytes compared to classical and intermediate 
monocytes. From dendritic cell subsets, expression of STRA6 was increased on the 
pDC subset compared to the mDC1 and mDC2 subsets. Interestingly, although all 
PBMC subsets express STRA6, confocal microscopy data analysis indicates its 
expression may not be co-localized with the plasma membrane, and specifically lipid 
raft regions, in PBMC subsets. Therefore, more research is needed to elucidate the 
cellular trafficking of STRA6 and its role in immune cells. 
Analysis of predictive demographic and anthropometric factors indicate that age 
is the most predictive factor in determining the level of expression of STRA6 on human 
immune cell subsets. In classical monocyte populations, age is a significant predictive 
factor of STRA6 expression, indicating an increased expression of STRA6 on classical 
monocytes as age increased. Therefore, these monocytes may have an increased 
requirement for, or response to, vitamin A in older individuals. Analyses also revealed 
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race/ethnicity and sex have a very low predictive power of STRA6 expression, 
suggesting that race/ethnicity and sex do not impact immune cells ability to uptake 
vitamin A. Body composition was also found to have a low predictive power on STRA6 
expression on immune cells. Neither body fat percentage nor BMI were predicative of 
STRA6 expression on immune cells.  
The low predictive power of body composition on STRA6 expression in immune 
cells is interesting considering the known intracellular signaling due to JAK/STAT 
activation. Upon holo-RBP binding to STRA6 the JAK2/STAT5 pathway is activated, 
resulting in the activation of SOCS3. Berry and colleagues discovered activation of this 
pathway impairs insulin receptor-mediated signaling, resulting in the development of 
insulin resistance in mice that had been injected with holo-RBP (Berry et. al., 2011). 
Insulin resistance is associated with an increase in abdominal fat accumulation, thus 
having an obvious impact on body composition (Kim & Park, 2018). The lack of body 
composition being a predictive factor for the expression of STRA6 support Berry and 
colleagues’ findings that insulin resistance resulting from this pathway is due holo-RBP 
and not STRA6 expression. This evidence explains why body composition is a low 
predictive factor of STRA6 expression.  
When considering predictive factors and these findings it is important to call 
attention to the limitations of our laboratory. PBMC included in this study were limited to 
those collected from human blood and may not be reflective of STRA6 expression on 
immune cells that have been trafficked to tissues or the gut. It is possible, and maybe 
even likely, that STRA6 expression of immune cells that have been trafficked out of the 
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circulatory system may have dissimilar expression of STRA6 compared to what is 
currently being reported.   
5. Conclusion 
 Vitamin A signaling in combination with JAK/STAT signaling via STRA6 
expression, now known to be present on all human PBMC subsets, allows vitamin A 
uptake to significantly contribute to immune cell homeostasis and may become 
increasingly important as one ages. Indicating a need to study differential expression of 
STRA6 on immune cells in chronic and infectious disease states.  
6. Future Direction 
 Future research in this area of study should focus on completing the confocal 
microscopy experiments. Experiments would further investigate the physical location of 
STRA6 in immune cells and give a better understanding of co-localization of STRA6 
with the plasma membrane and lipid raft giving better insight into function of STRA6 on 
immune cells. STRA6 expression should also be investigated on proliferating immune 
cells that are metabolically active to determine any differences in expression that may 
exist. Expression of STRA6 should be further investigated on T lymphocytes This would 
give explanation to differences that maybe be observed on TH1 vs TH2 or TH17 vs Treg 
subsets as well as effector vs memory subsets. This might also explain, differences 
seen in effector and memory subsets prior to and after influenza vaccination.  
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Appendix 
 
Appendix 1. Representative confocal microscopy images of differentiated ARPE-
19 cells. Panel A1-3, Cholera toxin subunit B AlexaFluor 488. Panel B1-3, STRA6 
AlexaFluor 647. Panel C1, merged images. Panel C2, Hoeschst. Panel C3, DIC image. 
Panel D2, merged images. Panel D3, Hoeschst. Panel E3, merged images. Alexa 
Fluor488 excited by the 488nm laser, emission collected 505nm-590nm. Alexa Fluor647 
excited by the 635nm laser, emission collected 650-770nm. Hoechst excited by 405nm 
laser, emission collected 410-520nm. STRA6 expression is intracellular and not co-
localized with the lipid raft or plasma membrane.  
 
